Pixantrone

Chemical formula: C₁₇H₁₉N₅O₂  Molecular mass: 325.372 g/mol  PubChem compound: 134019

Therapeutic indications

Pixantrone is indicated for:

Non-Hodgkin B-cell Lymphomas (NHL)

Population group: only adults (18 years old or older)

Pixantrone is indicated as monotherapy for the treatment of adult patients with multiply relapsed or refractory aggressive Non-Hodgkin B-cell lymphomas (NHL).

For this indication, competent medicine agencies globally authorize below treatments (click for details):

Contraindications

Pixantrone is contraindicated in the following cases:

Live virus vaccines

Live organism vaccines

Severe abnormal hepatic function

Hepatic failure stage IV

Profound bone marrow suppression

Myelosuppression

Get recommendations

Factors such as age, gender, and health history are evaluated to create a personalized medication regimen.

Ask the Reasoner

Related medicines

Summary of Product Characteristics (SPC) 2020: PIXUVRI Powder for concentrate for solution for infusion
< Previous: Overview
Next: Precautions >

© All content on this website, including data entry, data processing, decision support tools, "RxReasoner" logo and graphics, is the intellectual property of RxReasoner and is protected by copyright laws. Unauthorized reproduction or distribution of any part of this content without explicit written permission from RxReasoner is strictly prohibited. Any third-party content used on this site is acknowledged and utilized under fair use principles.

⇈